US WorldMeds to Present Final SPEARHEAD-1 Results for TECELRA® in Late-Breaking Oral Presentation at CTOS 2026
Results from all cohorts of the registrational trial selected for the session "Late Breaking Abstracts and Updates – Can They Change Practice?" LOUISVILLE, Ky., Nov. 17, 2026 /PRNewswire/ -- USWM CT, LLC (US WorldMeds) today announced that final results from all cohorts of the Phase 2...